For people living with MS, this is especially important because: If you are taking a GLP-1 medication, protecting muscle and bone health becomes an important part of your overall care plan
Published studies describe one molecule that acts on three receptor systems - GLP-1, GIP and glucagon - with body weight, blood sugar and liver fat tracked as trial results
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
Ask Key Questions: Ask about success rates, experience with specific procedures/medication, potential risks and complications, and the availability of post-treatment support and follow-up care